CareLit · DOI-Nachweis · Klinische Pädiatrie
Brain tumor immunotherapy. What have we learned so far?
DOI 10.1055/s-0035-1564670
Bibliografische Angaben
Nachweis in CareLit
Autor:innenSW Van Gool, J Dejaegher, S De Vleeschouwer
ZeitschriftKlinische Pädiatrie
Ausgabe11/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
High grade glioma (HGG) is a rare brain cancer, incurable in spite of modern neurosurgery, radiotherapy and chemotherapy. Novel approaches are in research, and immunotherapy emerges as a promising strategy. Clinical experiences with active specific immunotherapy demonstrate feasibility, safety and most importantly, but incompletely understood, prolonged long-term survival in a fraction of the patients. In relapsed p…
Zitieren
Zitierempfehlung
SW Van Gool, J Dejaegher, S De Vleeschouwer (2015) Brain tumor immunotherapy. What have we learned so far?. Klinische Pädiatrie (11). https://doi.org/10.1055/s-0035-1564670
Mit CareLit weiterarbeiten